Program
Chair - Prof. Christian Buske, Germany: Welcome and Introduction: Perceptual Evolution
Prof. László Gulásci, Hungary: Reducing Budgets, Increasing Access
Prof. João Gonçalves, Portugal: The Rationale of Biosimilarity
Prof. Won Seog Kim, Korea: Clinical Evidence of Biosimilar Rituximab
Panel Discussion: Biosimilar in Oncology: Yesterday, Today and
Interview with Prof. Won Seog Kim, MD, PhD, Sungkyunkwan University, Seoul, South Korea
Chair - Prof. Christian Buske, Germany: Welcome and Introduction: Perceptual Evolution from Oncoletter on Oncoletter.
Prof. László Gulásci, Hungary: Reducing Budgets, Increasing Access from Oncoletter on Oncoletter.
Prof. João Gonçalves, Portugal: The Rationale of Biosimilarity from Oncoletter on Oncoletter.
Prof. Won Seog Kim, Korea: Clinical Evidence of Biosimilar Rituximab from Oncoletter on Oncoletter.
Panel Discussion: Biosimilar in Oncology: Yesterday, Today and from Oncoletter on Oncoletter.
Interview with Prof. Won Seog Kim, MD, PhD, Sungkyunkwan University, Seoul, South Korea from Oncoletter on Oncoletter.